Managing Children With Renal Diseases During the COVID-19 Pandemic
Anil Vasudevan(College of Medicine & JNM Hospital), Om P. Mishra(Institute of Medical Sciences), Sanjeev Gulati(Fortis Hospital), Mukta Mantan(Maulana Azad Medical College), Georgie Mathew(Christian Medical College, Vellore), Priya Pais(St. John's National Academy of Health Sciences), Madhuri Kanitkar(Armed Forces Medical College), Arvind Bagga(All India Institute of Medical Sciences), Sriram Krishnamurthy(Schrodinger (United States)), Pankaj Hari(Indian Council of Medical Research)
Cited by 20
Related Papers
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203